# Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

> **NCT00155896** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 100 (—)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00155896
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2005-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00155896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00155896, "Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00155896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*